A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
Infusion Options is voluntarily recalling all lots of all sterile products within expiry to the hospital level. These products are being recalled due to a lack of assurance of sterility.